These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27505330)

  • 1. A novel polymer-free drug-eluting stent coated with everolimus using nitrogen-doped titanium dioxide film deposition in a porcine coronary restenosis model.
    Sim DS; Jeong MH; Park DS; Kim JH; Lim KS; Bae IH; Zhehao P; Yang HY; Lee JH; Hyun DY; Hong YJ; Kim JH; Ahn Y; Kang JC
    Int J Cardiol; 2016 Nov; 222():436-440. PubMed ID: 27505330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo evaluation of a novel polymer-free everolimus-eluting stent by nitrogen-doped titanium dioxide film deposition.
    Park DS; Bae IH; Jeong MH; Lim KS; Sim DS; Hong YJ; Lee SY; Jang EJ; Shim JW; Park JK; Lim HC; Kim HB
    Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():615-623. PubMed ID: 30033294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical Evaluation of a Novel Polymer-free Everolimus-eluting Stent in a Mid-term Porcine Coronary Restenosis Model.
    Cho KH; Jeong MH; Park DS; Kim M; Kim J; Park JK; Han X; Hyun DY; Kim MC; Sim DS; Hong YJ; Kim JH; Ahn Y
    J Korean Med Sci; 2021 Oct; 36(40):e259. PubMed ID: 34664799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of polymer-free TiO2 stent coated with abciximab or alpha lipoic acid in porcine coronary restenosis model.
    Lim KS; Jeong MH; Bae IH; Park JK; Park DS; Kim JM; Kim JH; Kim HS; Kim YS; Jeong HY; Song SJ; Yang EJ; Cho DL; Sim DS; Park KH; Hong YJ; Ahn Y
    J Cardiol; 2014 Nov; 64(5):409-18. PubMed ID: 24852847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparable vascular response of a new generation sirolimus eluting stents when compared to fluoropolymer everolimus eluting stents in the porcine coronary restenosis model.
    Buszman PP; Michalak MJ; Pruski M; Fernandez C; Jelonek M; Janas A; Savard C; Gwiazdowska-Nowotka B; Żurakowski A; Wojakowski W; Buszman PE; Milewski K
    Cardiol J; 2016; 23(6):657-666. PubMed ID: 27976797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of New Biodegradable Polymer-based Sirolimus-Eluting Stents in a Preclinical Model.
    Pérez de Prado A; Pérez Martínez C; Cuellas Ramón C; Regueiro Purriños M; López Benito M; Gonzalo Orden JM; Rodríguez Altónaga JA; Estévez Loureiro R; Benito González T; Viñuela Baragaño D; Molina Crisol M; Amorós Aguilar M; Pérez Serranos I; Vidal Parreu A; Benavides Montegordo A; Duocastella Codina L; Fernández Vázquez F
    Rev Esp Cardiol (Engl Ed); 2017 Dec; 70(12):1059-1066. PubMed ID: 28647315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).
    Alfonso F; Pérez-Vizcayno MJ; Cárdenas A; García Del Blanco B; Seidelberger B; Iñiguez A; Gómez-Recio M; Masotti M; Velázquez MT; Sanchís J; García-Touchard A; Zueco J; Bethencourt A; Melgares R; Cequier A; Dominguez A; Mainar V; López-Mínguez JR; Moreu J; Martí V; Moreno R; Jiménez-Quevedo P; Gonzalo N; Fernández C; Macaya C;
    J Am Coll Cardiol; 2014 Apr; 63(14):1378-86. PubMed ID: 24412457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful implantation of a novel polymer-free everolimus-eluting stent using nitrogen-doped titanium dioxide film with good patency on follow-up angiography: A case report.
    Oh S; Jeong MH; Park DS; Kim M; Kim JH; Hyun DY; Cho KH; Kim MC; Sim DS; Hong YJ; Kim JH; Ahn Y
    Medicine (Baltimore); 2022 Jul; 101(29):e29666. PubMed ID: 35866823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Novel Polymer-Free Nitrogen-Doped Titanium Dioxide Film-Coated Coronary Stent Loaded With Mycophenolic Acid.
    Shim JW; Kim SS; Kim HK; Bae IH; Park DS; Park JK; Kim JU; Kim HB; Lee MY; Kim JS; Kim JH; Koo BS; Jeong KJ; Kim SU; Kim MC; Sim DS; Hong YJ; Ahn Y; Lim KS; Jeong MH
    Front Bioeng Biotechnol; 2021; 9():650408. PubMed ID: 34778222
    [No Abstract]   [Full Text] [Related]  

  • 10. A novel polymer-free everolimus-eluting stent with a nitrogen-doped titanium dioxide film inhibits restenosis and thrombosis in a swine coronary model.
    Hyun DY; Han X; Park DS; Kim M; Park JK; Cho KH; Sim DS; Hong YJ; Ahn Y; Jeong MH
    Cardiol J; 2023 Feb; 30(6):881-91. PubMed ID: 36790043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SYNERGY biodegradable polymer everolimus eluting coronary stent: Porcine vascular compatibility and polymer safety study.
    Wilson GJ; Marks A; Berg KJ; Eppihimer M; Sushkova N; Hawley SP; Robertson KA; Knapp D; Pennington DE; Chen YL; Foss A; Huibregtse B; Dawkins KD
    Catheter Cardiovasc Interv; 2015 Nov; 86(6):E247-57. PubMed ID: 26009986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Thrombogenicity of a Durable Polymer Everolimus-Eluting Stent Relative to Contemporary Drug-Eluting Stents With Biodegradable Polymer Coatings Assessed Ex Vivo in a Swine Shunt Model.
    Otsuka F; Cheng Q; Yahagi K; Acampado E; Sheehy A; Yazdani SK; Sakakura K; Euller K; Perkins LEL; Kolodgie FD; Virmani R; Joner M
    JACC Cardiovasc Interv; 2015 Aug; 8(9):1248-1260. PubMed ID: 26292590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
    Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
    Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental efficacy of an everolimus eluting cobalt chromium stent.
    Carter AJ; Brodeur A; Collingwood R; Ross S; Gibson L; Wang CA; Haller S; Coleman L; Virmani R
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):97-103. PubMed ID: 16755598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Efficacy of Paclitaxel-Eluting Balloon Catheters and Everolimus-Eluting Stents in the Treatment of Coronary In-Stent Restenosis: The Treatment of In-Stent Restenosis Study.
    Pleva L; Kukla P; Kusnierova P; Zapletalova J; Hlinomaz O
    Circ Cardiovasc Interv; 2016 Apr; 9(4):e003316. PubMed ID: 27069104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.
    Adriaenssens T; Dens J; Ughi G; Coosemans M; Onsea K; Dubois C; Sinnaeve P; Vrolix M; Desmet W
    EuroIntervention; 2011 May; 7 Suppl K():K100-5. PubMed ID: 22027717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.
    Almalla M; Pross V; Marx N; Hoffmann R
    Coron Artery Dis; 2012 Nov; 23(7):492-6. PubMed ID: 22990414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental study of Mytrolimus-eluting stents on preventing restenosis in porcine coronary model].
    Qiu H; Gao RL; Tang ZR; Meng L; Zhao H; Ruan YM; Zhao H; Yang YJ; Chen JL; Chen ZJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jun; 33(6):561-4. PubMed ID: 16053797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
    Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
    Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis of Drug-Eluting Stents: The RIBS IV Randomized Clinical Trial.
    Alfonso F; Pérez-Vizcayno MJ; Cárdenas A; García del Blanco B; García-Touchard A; López-Minguéz JR; Benedicto A; Masotti M; Zueco J; Iñiguez A; Velázquez M; Moreno R; Mainar V; Domínguez A; Pomar F; Melgares R; Rivero F; Jiménez-Quevedo P; Gonzalo N; Fernández C; Macaya C;
    J Am Coll Cardiol; 2015 Jul; 66(1):23-33. PubMed ID: 26139054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.